Whole-brain radiotherapy in patients with brain metastases from melanoma

by de la Fuente, Macarena, Beal, Kathryn, Carvajal, Richard, Kaley, Thomas J
Published in CNS Oncol (2014)

Radiographic patterns of recurrence and pathologic correlation in malignant gliomas treated with bevacizumab

by Thomas, Alissa, Rosenblum, Marc, Karimi, Sasan, DeAngelis, Lisa M, Omuro, Antonio, Kaley, Thomas J
Published in CNS Oncol (2018)

Bevacizumab in high-grade glioma patients following intraparenchymal hemorrhage

by Lin, Xuling, Daras, Mariza, Pentsova, Elena, Nolan, Craig P., Gavrilovic, Igor T., DeAngelis, Lisa M., Kaley, Thomas J.
Published in Neurooncol Pract (2017)

Phase I Study of RO4929097 with Bevacizumab in Patients with Recurrent Malignant Glioma

by Pan, Edward, Supko, Jeffrey G., Kaley, Thomas J., Butowski, Nicholas A., Cloughesy, Timothy, Jung, Jinkyu, Desideri, Serena, Grossman, Stuart, Ye, Xiaobu, Park, Deric M.
Published in J Neurooncol (2016)

Phase II trial of an AKT inhibitor (perifosine) for recurrent glioblastoma

by Kaley, Thomas J., Panageas, Katherine S., Mellinghoff, Ingo K., Nolan, Craig, Gavrilovic, Igor T., DeAngelis, Lisa M., Abrey, Lauren E., Holland, Eric C., Lassman, Andrew B.
Published in J Neurooncol (2019)

Genomic Heterogeneity Underlies Mixed Response to Tropomyosin Receptor Kinase Inhibition in Recurrent Glioma

by Schram, Alison M., Jonsson, Philip, Drilon, Alexander, Bale, Tejus A., Hechtman, Jaclyn F., Benayed, Ryma, Hanusch, Bethany, Young, Robert J., Grommes, Christian, Ku, Nora, Kaley, Thomas J., Hyman, David M., Taylor, Barry S.
Published in JCO Precis Oncol (2018)

A phase I study of cediranib in combination with cilengitide in patients with recurrent glioblastoma

by Gerstner, Elizabeth R., Ye, Xiaobu, Duda, Dan G., Levine, Michael A., Mikkelsen, Tom, Kaley, Thomas J., Olson, Jeffrey J., Nabors, Burt L., Ahluwalia, Manmeet S., Wen, Patrick Y., Jain, Rakesh K., Batchelor, Tracy T., Grossman, Stuart
Published in Neuro Oncol (2015)

Phase I clinical trial of temsirolimus and perifosine for recurrent glioblastoma

by Kaley, Thomas J., Panageas, Katherine S., Pentsova, Elena I., Mellinghoff, Ingo K., Nolan, Craig, Gavrilovic, Igor, DeAngelis, Lisa M., Abrey, Lauren E., Holland, Eric C., Omuro, Antonio, Lacouture, Mario E., Ludwig, Emmy, Lassman, Andrew B.
Published in Ann Clin Transl Neurol (2020)

R-MPV followed by high-dose chemotherapy with TBC and autologous stem-cell transplant for newly diagnosed primary CNS lymphoma

by Omuro, Antonio, Correa, Denise D., DeAngelis, Lisa M., Moskowitz, Craig H., Matasar, Matthew J., Kaley, Thomas J., Gavrilovic, Igor T., Nolan, Craig, Pentsova, Elena, Grommes, Christian C., Panageas, Katherine S., Baser, Raymond E., Faivre, Geraldine, Abrey, Lauren E., Sauter, Craig S.
Published in Blood (2015)

Phase II trial of continuous low-dose temozolomide for patients with recurrent malignant glioma

by Omuro, Antonio, Chan, Timothy A., Abrey, Lauren E., Khasraw, Mustafa, Reiner, Anne S., Kaley, Thomas J., DeAngelis, Lisa M., Lassman, Andrew B., Nolan, Craig P., Gavrilovic, Igor T., Hormigo, Adilia, Salvant, Cynthia, Heguy, Adriana, Kaufman, Andrew, Huse, Jason T., Panageas, Katherine S., Hottinger, Andreas F., Mellinghoff, Ingo
Published 2013

Phase II trial of sunitinib for recurrent and progressive atypical and anaplastic meningioma

by Kaley, Thomas J., Wen, Patrick, Schiff, David, Ligon, Keith, Haidar, Sam, Karimi, Sasan, Lassman, Andrew B., Nolan, Craig P., DeAngelis, Lisa M., Gavrilovic, Igor, Norden, Andrew, Drappatz, Jan, Lee, Eudocia Quant, Purow, Benjamin, Plotkin, Scott R., Batchelor, Tracy, Abrey, Lauren E., Omuro, Antonio
Published in Neuro Oncol (2015)

Phase 1b trial of an ibrutinib-based combination therapy in recurrent/refractory CNS lymphoma

by Grommes, Christian, Tang, Sarah S., Wolfe, Julia, Kaley, Thomas J., Daras, Mariza, Pentsova, Elena I., Piotrowski, Anna F., Stone, Jacqueline, Lin, Andrew, Nolan, Craig P., Manne, Malbora, Codega, Paolo, Campos, Carl, Viale, Agnes, Thomas, Alissa A., Berger, Michael F., Hatzoglou, Vaios, Reiner, Anne S., Panageas, Katherine S., DeAngelis, Lisa M., Mellinghoff, Ingo K.
Published in Blood (2019)

Phase II study of monthly pasireotide LAR (SOM230C) for recurrent or progressive meningioma

by Norden, Andrew D., Ligon, Keith L., Hammond, Samantha N., Muzikansky, Alona, Reardon, David A., Kaley, Thomas J., Batchelor, Tracy T., Plotkin, Scott R., Raizer, Jeffrey J., Wong, Eric T., Drappatz, Jan, Lesser, Glenn J., Haidar, Sam, Beroukhim, Rameen, Lee, Eudocia Q., Doherty, Lisa, Lafrankie, Debra, Gaffey, Sarah C., Gerard, Mary, Smith, Katrina H., McCluskey, Christine, Phuphanich, Surasak, Wen, Patrick Y.
Published in Neurology (2015)

Phase II Study of Bevacizumab, Temozolomide and Hypofractionated Stereotactic Radiotherapy for Newly Diagnosed Glioblastoma

by Omuro, Antonio, Beal, Kathryn, Gutin, Philip, Karimi, Sasan, Correa, Denise D., Kaley, Thomas J., DeAngelis, Lisa M., Chan, Timothy A., Gavrilovic, Igor T., Nolan, Craig, Hormigo, Adilia, Lassman, Andrew B., Mellinghoff, Ingo, Grommes, Christian, Reiner, Anne S., Panageas, Katherine S., Baser, Raymond E., Tabar, Viviane, Pentsova, Elena, Sanchez, Juan, Barradas-Panchal, Renata, Zhang, Jianan, Faivre, Geraldine, Brennan, Cameron W., Abrey, Lauren E., Huse, Jason T.
Published in Clin Cancer Res (2014)

A Multicenter, Phase II, Randomized, Noncomparative Clinical Trial of Radiation and Temozolomide with or without Vandetanib in Newly Diagnosed Glioblastoma Patients

by Lee, Eudocia Q., Kaley, Thomas J., Duda, Dan G., Schiff, David, Lassman, Andrew B., Wong, Eric T., Mikkelsen, Tom, Purow, Benjamin W., Muzikansky, Alona, Ancukiewicz, Marek, Huse, Jason T., Ramkissoon, Shakti, Drappatz, Jan, Norden, Andrew D., Beroukhim, Rameen, Weiss, Stephanie E., Alexander, Brian M., McCluskey, Christine S., Gerard, Mary, Smith, Katrina H., Jain, Rakesh K., Batchelor, Tracy T., Ligon, Keith L., Wen, Patrick Y.
Published in Clin Cancer Res (2015)

Multicenter Phase IB Trial of Carboxyamidotriazole Orotate and Temozolomide for Recurrent and Newly Diagnosed Glioblastoma and Other Anaplastic Gliomas

by Omuro, Antonio, Beal, Kathryn, McNeill, Katharine, Young, Robert J., Thomas, Alissa, Lin, Xuling, Terziev, Robert, Kaley, Thomas J., DeAngelis, Lisa M., Daras, Mariza, Gavrilovic, Igor T., Mellinghoff, Ingo, Diamond, Eli L., McKeown, Andrew, Manne, Malbora, Caterfino, Andrew, Patel, Krishna, Bavisotto, Linda, Gorman, Greg, Lamson, Michael, Gutin, Philip, Tabar, Viviane, Chakravarty, Debyani, Chan, Timothy A., Brennan, Cameron W., Garrett-Mayer, Elizabeth, Karmali, Rashida A., Pentsova, Elena
Published in J Clin Oncol (2018)

Integration of 2-hydroxyglutarate-proton magnetic resonance spectroscopy into clinical practice for disease monitoring in isocitrate dehydrogenase-mutant glioma

by de la Fuente, Macarena I., Young, Robert J., Rubel, Jennifer, Rosenblum, Marc, Tisnado, Jamie, Briggs, Samuel, Arevalo-Perez, Julio, Cross, Justin R., Campos, Carl, Straley, Kimberly, Zhu, Dongwei, Dong, Chuanhui, Thomas, Alissa, Omuro, Antonio A., Nolan, Craig P., Pentsova, Elena, Kaley, Thomas J., Oh, Jung H., Noeske, Ralph, Maher, Elizabeth, Choi, Changho, Gutin, Philip H., Holodny, Andrei I., Yen, Katharine, DeAngelis, Lisa M., Mellinghoff, Ingo K., Thakur, Sunitha B.
Published in Neuro Oncol (2016)

Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma

by Cloughesy, Timothy F., Mochizuki, Aaron Y., Orpilla, Joey R., Hugo, Willy, Lee, Alexander H., Davidson, Tom B., Wang, Anthony C., Ellingson, Benjamin M., Rytlewski, Julie A., Sanders, Catherine M., Kawaguchi, Eric S., Du, Lin, Li, Gang, Yong, William H., Gaffey, Sarah C., Cohen, Adam L., Mellinghoff, Ingo K., Lee, Eudocia Q., Reardon, David A., O’Brien, Barbara J., Butowski, Nicholas A., Nghiemphu, Phioanh L., Clarke, Jennifer L., Arrillaga-Romany, Isabel C., Colman, Howard, Kaley, Thomas J., de Groot, John F., Liau, Linda M., Wen, Patrick Y., Prins, Robert M.
Published in Nat Med (2019)

Ibrutinib Unmasks Critical Role of Bruton Tyrosine Kinase in Primary CNS Lymphoma

by Grommes, Christian, Pastore, Alessandro, Palaskas, Nicolaos, Tang, Sarah S., Campos, Carl, Schartz, Derrek, Codega, Paolo, Nichol, Donna, Clark, Owen, Hsieh, Wan-Ying, Rohle, Dan, Rosenblum, Marc, Viale, Agnes, Tabar, Viviane S, Brennan, Cameron W, Gavrilovic, Igor T., Kaley, Thomas J, Nolan, Craig P, Omuro, Antonio, Pentsova, Elena, Thomas, Alissa A, Tsyvkin, Elina, Noy, Ariela, Palomba, M. Lia, Hamlin, Paul, Sauter, Craig S., Moskowitz, Craig H., Wolfe, Julia, Dogan, Ahmet, Won, Minhee, Glass, Jon, Peak, Scott, Lallana, Enrico C, Hatzoglou, Vaios, Reiner, Anne S, Gutin, Philip H, Huse, Jason T, Panageas, Katherine S, Graeber, Thomas G, Schultz, Nikolaus, DeAngelis, Lisa M, Mellinghoff, Ingo K
Published in Cancer Discov (2017)

Genomic correlates of disease progression and treatment response in prospectively characterized gliomas

by Jonsson, Philip, Lin, Andrew L., Young, Robert J., DiStefano, Natalie M., Hyman, David M., Li, Bob T., Berger, Michael F., Zehir, Ahmet, Ladanyi, Marc, Solit, David B., Arnold, Angela G., Stadler, Zsofia K., Mandelker, Diana, Goldberg, Michael E., Chmielecki, Juliann, Pourmaleki, Maryam, Ogilvie, Shahiba Q., Chavan, Shweta S., McKeown, Andrew T., Manne, Malbora, Hyde, Allison, Beal, Kathryn, Yang, T. Jonathan, Nolan, Craig P., Pentsova, Elena, Omuro, Antonio, Gavrilovic, Igor T., Kaley, Thomas J., Diamond, Eli L., Stone, Jacqueline B., Grommes, Christian, Boire, Adrienne, Daras, Mariza, Piotrowski, Anna F., Miller, Alexandra M., Gutin, Philip H., Chan, Timothy A., Tabar, Viviane S., Brennan, Cameron W., Rosenblum, Marc, DeAngelis, Lisa M., Mellinghoff, Ingo K., Taylor, Barry S.
Published in Clin Cancer Res (2019)